Adelaide Facility Commissioning Risk
TGA licensing expected by March 31 next year. Clean rooms, utilities, and equipment validation ongoing. Commissioning delays could impact FY28 vertical integration benefits.
SAIPARENT / Q4-FY26 / risks
Keep the risk register visible.
Sai Parenterals · Material risks, their source context, and severity in the latest available quarter.
Research layer active
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Risk intelligence
Material risks this quarter
high
Customer Concentration in Australia
Numed derives significant revenue from two top 20 ASX customers—Westfarmers Health and EBOS Group. Loss of either relationship could materially impact Australian segment performance.
PBT Decline Despite Revenue Growth
Analyst raised concern: consolidated PBT decreased to Rs 18.85 crore from Rs 14.4 crore YoY despite revenue doubling. Management attributed to acquisition costs and integration expenses but did not provide detailed breakdown.
AUD 40 Million Remaining Australian Capex
Of the AUD 53 million total Adelaide investment, AUD 40 million has been invested. Balance capex needs to be deployed and commissioned by Q4 FY27, requiring continued cash deployment during peak debt period.